Regulations.gov document
Reference 7 FDA_Regulatory Considerations for Peptide Drug Products PPT re Citizen…
Supporting & Related Material · FDA-2017-P-6029 · posted Oct 6, 2017
Key facts
| Document ID | FDA-2017-P-6029-0010 |
|---|---|
| Title | Reference 7 FDA_Regulatory Considerations for Peptide Drug Products PPT re Citizen Petition from Novo Nordisk Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2017-P-6029 |
| Posted | Oct 6, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: